![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/00 |
(11) | Number of the document | 3193919 |
(13) | Kind of document | T |
(96) | European patent application number | 15842660.1 |
Date of filing the European patent application | 2015-09-15 | |
(97) | Date of publication of the European application | 2017-07-26 |
(45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/050270 |
Date | 2015-09-15 |
(87) | Number | WO 2016/044326 |
Date | 2016-03-24 |
(30) | Number | Date | Country code |
201462050567 P | 2014-09-15 | US |
(72) |
YU, Cheng-der Tony, TW
HSIEH, Yih Huang, TW
CHEN, I Ju, TW
LEE, Wei-han, TW
WANG, Nan-hsuan, TW
|
(73) |
OBI Pharma, Inc.,
Room W1907, 19F, 3 Yuan-Qu Street Nanking District, Tapei City, 11503,
TW
|
(54) | IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF |
IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF |